Human Pluripotent Stem Cell Core
The Human Pluripotent Stem Cell facility continuously evaluates emerging technologies and is now offering both feeder-based and feeder-free cultures in chemically defined mTeSR or in N2/B27 media. The Core is currently offering the generation of iPS cells with two transgene-free methods: 1) using episomes (based on the Yamanaka plasmids); or 2) using Sendai virus.
Reprogramming of fibroblasts or blood cells into Induced human pluripotent stem cell (iPSCs).
Gene editing in iPSCs
Site-specific insertions in iPSCs
Human embryonic stem cells (hESCs) culture
Production of hematopoietic stem and progenitor cells from iPSCs (iHSPCs)
Production of microglia from iPSCs (iMGs)
Production of mesenchymal stem cells from iPSCs (iMSCs)
Processing of primary tissue (blood, skin biopsy etc…)
Production of fibroblast culture
Location and Contacts
Human Pluripotent Stem Cell Core Ullmann 925
Eric Bouhassira, Ph.D.
Scientific Director